RO

Rashid O P

Active Director Director DIN 11434245
DIN 11434245 First appointment Dec 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Rashid O P

Data last updated:

Rashid O P is a Director at Klen Lifeveda Private Limited (since 2025). The company operates in Healthcare.

DIN 11434245
Primary Designation Director
Industry Healthcare
First Appointment 16 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Klen Lifeveda Private Limited U47721KL2025PTC099325
Director16 Dec 20252025Active

Board colleagues of Rashid O P

NameDINCompanyDesignation
Vineeth Manathil Viswanathan08053057Klen Lifeveda Private LimitedDirector

Directorship timeline

Open interactive timeline →
Klen Lifeveda Private Limited
Premium access

Shareholding and investment profile for Rashid O P

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rashid O P

Rashid O P currently holds 1 directorship: Klen Lifeveda Private Limited (Director, since 16 Dec 2025).

Rashid O P was first appointed on 16 Dec 2025 as Director at Klen Lifeveda Private Limited.

The current boards of Rashid O P's companies include Vineeth Manathil Viswanathan (Klen Lifeveda Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available